Compare Coinbase Global, Inc. (COIN) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coinbase Global, Inc. vs ResMed Inc. — how do they compare? Coinbase Global, Inc. trades at $181.53 (market cap $45.38B), while ResMed Inc. trades at $228.88 (market cap $31.89B). The key difference: Coinbase Global, Inc. is the larger of the two by market cap, and ResMed Inc. pays a 1.16% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Coinbase Global, Inc. for 78 Days and ResMed Inc. for 51 Days on average.
| COIN | RMD | |
|---|---|---|
Market Cap | $45.38B | $31.89B |
Volume | 11,013,940 | 618,314 |
Sector | Financials | Health |
52-Week High | $387.00 | $277.88 |
52-Week Low | $141.09 | $182.82 |
Typical Hold Time | 78 Days | 51 Days |
Enterprise Value | $43.03B | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COIN trades at $178.45, down 3.92% in 24 hours, with a bearish technical signal and support near $173. The company reported revenue of $7.18B in 2025 with a net income of $1.26B, though recent quarters have missed EPS expectations. Positive developments include CFTC approval for derivatives clearing and expanded partnerships with Citigroup, driving institutional optimism.
The stock presents a mixed outlook: analyst consensus is bullish with a $211.55 price target, but high valuation ratios and volatile earnings pose risks. Regulatory scrutiny and crypto market dependence remain key concerns for sustained growth.
ResMed (RMD) trades at $228.37, up 1.06% today, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15B in 2025, with a robust net income margin of 26.94%. Recent news highlights management's presentation at the Morgan Stanley Healthcare Conference and an upcoming Q1 2027 earnings report.
The outlook is positive, supported by earnings growth targets of 12-14% and a consensus price target of $242.70. Key risks include competitive pressures and ongoing legal investigations. Institutional buying activity and analyst upgrades reflect confidence, but investors should monitor execution against growth targets and any developments from the legal probe.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
